• Genetic Drug Sensitivity Testing, Simplified

    PGXL’s panel eases the management of pharmaceutical therapy to give physicians the whole picture, predicting how drugs will interact with each other and the patient’s genetics, in a single report. More

    Tubes 619

  • The Ability to Do More

    Researchers who need to add genetics to their trial design need a partner that brings more than testing capabilities to the table. PGXL’s scientists have participated in hundreds of trials, and no one knows more about incorporating genetics into clinical trials than we do. More

  • Single Cell Recovery and Characterization

    Genetic variation in tumors and circulating tumor cells can play a role in disease progression and treatment. PGXL’s exclusive single cell sorting and isolation provides molecular information at the level of individual cells.  More.

    Silicon Bio Art 619

About PGxl

PGXL is an internationally recognized pioneer in the application of pharmacogenetics to personalized medicine.  The company was founded in 2005 by Dr. Roland Valdes, Jr., and Dr. Mark W. Linder, researchers who are worldwide thought leaders in the science underlying personalized medicine. The lab is CLIA and CAP certified, and has been set-up to provide quick and accurate testing for both clinical use and research.

You can follow PGXL on Twitter @PGXLlabs


PGxl Blog